Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Check Cap Ltd (CHEK)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Check Cap Ltd's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2.1750 -0.0050    -0.23%
11:03:22 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 3,833
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 2.1200 - 2.1800
Check Cap Ltd 2.1750 -0.0050 -0.23%

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

CHEK Comments

Write your thoughts about Check Cap Ltd
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
jyotsna singhal
jyotsna singhal Nov 28, 2022 3:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What’s going on really 🥹🥹🥹
Reply
0 0
Report
Vladimir Ivanov
Vladimir Ivanov Aug 29, 2022 3:10PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$10 in few weeks! (after r/s)
Reply
0 0
Report
Vladimir Ivanov
Vladimir Ivanov Jun 21, 2022 8:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
today is the day!
Reply
1 0
Report
Sandeep Karwa
Sandeep Karwa Jun 21, 2022 8:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What is the good news ?
Reply
0 0
Report
yesyes yes yes yes
yesyes yes yes yes Apr 21, 2022 7:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This is an easy $2.50 stock on trials ending
Reply
1 0
Report
Vincent Ornells
Vincent Ornells Apr 01, 2022 1:46PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Clinical trials begin April 15th 2022
Reply
3 0
Report
Sandeep Karwa
Sandeep Karwa Apr 01, 2022 1:46PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
How is the outlook short and long term ?
Reply
0 0
Report
DEMOLITION MIND
DEMOLITION MIND Feb 07, 2022 10:24PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Fda approval of pivotal study!!!
Reply
1 0
Report
DEMOLITION MIND
DEMOLITION MIND Feb 01, 2022 8:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
We may see the moon soon
Reply
0 0
Report
DEMOLITION MIND
DEMOLITION MIND Dec 09, 2021 3:30AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Countdown..
Reply
0 0
Report
DEMOLITION MIND
DEMOLITION MIND Dec 03, 2021 4:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Com’oooon maaan!!!!
Reply
1 1
Report
DEMOLITION MIND
DEMOLITION MIND Nov 25, 2021 2:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
For those new to Check Cap Here are some key pointsCheck Cap's C-Scan pill for colonoscopy has been approved for use in Isreal since 2018. https://www.prnewswire.com/news-releases/check-cap-receives-approval-from-the-israeli-ministry-of-health-to-initiate-commercial-sales-in-israel-of-its-c-scan-system-300706973.htmlCheck Cap's Scan tech requires no preparatory procedure which makes follow through with the procedure much easier and less impactful to individual's lives. Patients do not have to experience pain and discomfort from procedure like they do colonoscopies. They also do not need the same facility use as a colonoscopy allowing people to save time.The FDA is particularly interested in Chek because roughly 40% of Americans who should get a colonoscopies don't. Existing non-invasive colon screening is less acurate than C-scan Tech used by Check Cap.Recent study https://www.businesswire.com/news/home/20150428006203/en/New-Study-Reveals-People-Avoid-Colonoscopy
Reply
1 0
Report
DEMOLITION MIND
DEMOLITION MIND Nov 25, 2021 2:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
28 percent do not feel it is necessary20.1 percent say it’s too expensive20.1 percent dislike the procedure itself (addressed by Check Cap)15.8 percent rely on other methods to avoid colon cancer (addressed by Check Cap)6.5 percent do not know they are supposed to get one6.5 percent are too busy with other priorities (addressed by Check Cap)Additionally Chek has already raised a large amount of capitolthis year that it expects will carry it through a stage 3 study for the US. Simplywall.st reports they should have enough capitol for 3 years of funding, but this does not account for large scale studies like a phase II and III trial. Covid delayed C-Scan US clinical testing as the FDA was unable to get to Israel in order to inspect the facility.Covid also highlighted challenges to Check Cap's supply chain as they previously used a single supplier, this is something management has been addressing and they have expressed confidence that their expansion and supply chain changes wi
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close

Make Smart Decisions.
Research, evaluate, and invest with unique market insights

Volatile markets create opportunities.
Don’t miss out.

Investing Insights
Investing Insights
Investing Insights

Read More

Invest with knowledge

Leverage the wisdom of financial experts and seize market opportunities.

  • Generate investment ideas based on leading Wall Street analyst recommendations.

  • Research trending stocks using 6 unique market factors.

  • Receive market updates in our Insights Newsletter.

Why Investing Insights

5 ways to boost your research

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

Stay Ahead. Learn From the Pros.

For the stocks you research, we’ll bring you insights from

  • 6,500 Wall Street analysts

  • 40,000 corporate insiders

  • 7,000 financial bloggers

  • 200 leading hedge funds

  • 100,000 news stories daily

  • 100s of investment ideas

* For the U.S. stock market. We are continually expanding coverage.

Questions & Answers

  • What is Investing Insights?

    Investing Insights is a premium service that provides you with actionable insights from thousands of financial experts that cover the US stock market. Find out which stocks Wall Street analysts, insiders, financial bloggers, hedge fund managers and individual investors are recommending. Investing Insights is available only on our website. Canadian and UK stock markets will soon be added.

  • What is "Smart Score"?

    Smart Score is a powerful scoring system that ranks stocks on a scale of 1-10 based on 6 unique market factors. Smart Score is updated every evening after the market closes, 5 days a week.

  • Can I try Investing Insights for free?

    Yes. You can try Investing Insights for 14 days free of charge.
    The trial period will be followed by a paid subscription. To avoid being charged simply contact our support to cancel the subscription before the trial period ends.
    Please notice that purchases made through PayPal might be subjected to a temporary authorization.

  • How do I cancel my Investing Insights premium subscription?

    In order to cancel your subscription, please contact our support with your registered email or reference number and one of our agents will be happy to assist you.

  • Will I get notified before my subscription renewal?

    Our subscription has automatic renewal, meaning that when you reach the subscription end date, you will be charged automatically and your subscription will be extended. You can cancel your subscription anytime by following the instructions in the answer to the "How do I cancel my Investing Insights subscription" question. The subscription will remain active for the duration of the paid period.

  • What are the available payment methods?

    We accept all major credit cards and debit cards, including Visa, Mastercard, American Express, Discover, JCB, and Diners. Additional payment options may be available in your specific location

Got more questions?

We hope you found the answers you were looking for. You can read more about Insights here. Please go to the Investing Help Center for further information.

By subscribing you agree to TipRanks' Terms and Conditions and Privacy Policy

Powered by
Continue with Google
or
Sign up with Email